Asthma Self-Management in Older Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00941694
Recruitment Status : Completed
First Posted : July 20, 2009
Last Update Posted : January 16, 2013
Information provided by (Responsible Party):
Alan Baptist, University of Michigan

Brief Summary:
Asthma self-management is an effective way to improve the outcomes of patients with asthma. However, to be most effective these interventions should be targeted and designed toward a specific population or group. There is currently no asthma self-management intervention directed towards older adults. The hypothesis is that a 6-session asthma self-management intervention will improve the outcomes of older patients with asthma.

Condition or disease Intervention/treatment Phase
Asthma Aged Behavioral: Self management intervention Behavioral: placebo group Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 70 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Asthma Self-Management in Older Adults
Study Start Date : July 2009
Actual Primary Completion Date : December 2012
Actual Study Completion Date : December 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Asthma
U.S. FDA Resources

Arm Intervention/treatment
Experimental: Self-Management Intervention
Will receive 6 asthma self-management group or individual session over a 7 week period
Behavioral: Self management intervention
Intervention arm will receive 6 group or individual sessions over a 7 week period
Placebo Comparator: Control
Group will receive 3 phone calls not related to asthma self management over a 7 week period
Behavioral: placebo group
3 phone calls not related to asthma self-management

Primary Outcome Measures :
  1. Asthma Quality of Life Questionnaire [ Time Frame: 3 months, 6 months, 1 year ]

Secondary Outcome Measures :
  1. Asthma Control Questionnaire [ Time Frame: 3 months, 6 months, 12 months ]
  2. Health Care Utilization [ Time Frame: 3 months, 6 months, 12 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   65 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:: Age over 65, physician diagnosed asthma, need for daily asthma control medication, access to a telephone.

Exclusion Criteria: Smoking history greater than 40 pack years, current smoker, mental impairment that would preclude participation in the asthma self management program

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00941694

United States, Michigan
University of Michigan
Ann Arbor, Michigan, United States, 48105
Sponsors and Collaborators
University of Michigan
Principal Investigator: Alan P Baptist, MD University of Michigan

Responsible Party: Alan Baptist, Assistant Professor, University of Michigan Identifier: NCT00941694     History of Changes
Other Study ID Numbers: N011060
First Posted: July 20, 2009    Key Record Dates
Last Update Posted: January 16, 2013
Last Verified: January 2013

Keywords provided by Alan Baptist, University of Michigan:
self care

Additional relevant MeSH terms:
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases